CSPC Pharmaceutical Group Limited (HKG:1093)

CSPC Pharmaceutical Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	63,201	55,169	86,022	97,707	100,932	94,800
Market Cap Growth	-35.87%	-35.87%	-11.96%	-3.19%	6.47%	-18.19%
Enterprise Value	55,722	45,415	74,600	84,557	88,212	87,594
Last Close Price	5.53	4.78	6.92	7.51	7.56	6.97
PE Ratio	14.09	11.98	13.30	14.19	14.67	15.47
Forward PE	12.08	9.76	12.05	13.86	15.70	15.49
PS Ratio	2.05	1.79	2.48	2.79	2.95	3.20
PB Ratio	1.75	1.53	2.23	2.73	3.07	3.46
P/TBV Ratio	2.01	1.76	2.53	3.08	3.24	3.68
P/FCF Ratio	23.57	20.58	30.56	15.99	25.49	14.83
P/OCF Ratio	13.10	11.43	18.68	11.33	17.73	11.84
PEG Ratio	1.67	1.03	1.03	1.03	1.03	1.03
EV/Sales Ratio	1.81	1.47	2.15	2.42	2.58	2.96
EV/EBITDA Ratio	8.02	6.62	8.53	9.83	10.31	11.98
EV/EBIT Ratio	9.92	7.95	9.65	11.07	11.50	13.48
EV/FCF Ratio	20.78	16.94	26.50	13.83	22.27	13.70
Debt / Equity Ratio	0.02	0.02	0.02	0.02	0.00	0.01
Debt / EBITDA Ratio	0.08	0.08	0.09	0.08	0.01	0.05
Debt / FCF Ratio	0.20	0.20	0.28	0.11	0.03	0.06
Asset Turnover	0.64	0.64	0.71	0.81	0.86	0.89
Inventory Turnover	2.78	2.78	3.26	3.45	3.10	2.85
Quick Ratio	1.95	1.95	2.32	2.39	2.47	2.22
Current Ratio	2.27	2.27	2.63	2.67	2.81	2.53
Return on Equity (ROE)	12.60%	12.60%	18.22%	21.32%	22.79%	24.54%
Return on Assets (ROA)	7.40%	7.40%	9.96%	11.04%	12.05%	12.13%
Return on Capital (ROIC)	9.57%	9.57%	12.91%	14.29%	15.52%	15.86%
Return on Capital Employed (ROCE)	15.40%	15.40%	19.40%	20.60%	22.70%	23.00%
Earnings Yield	7.29%	8.35%	7.52%	7.05%	6.82%	6.46%
FCF Yield	4.24%	4.86%	3.27%	6.26%	3.92%	6.74%
Dividend Yield	4.73%	5.44%	4.11%	2.88%	2.47%	1.83%
Payout Ratio	74.72%	74.72%	46.42%	34.42%	30.16%	29.61%
Buyback Yield / Dilution	1.14%	1.14%	0.38%	0.29%	0.01%	0.00%
Total Shareholder Return	5.86%	6.58%	4.49%	3.17%	2.48%	1.83%

Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.